The World Health Organization estimated that 38 million people worldwide were living with HIV at the end of 2019.1 Less than 30% of HIV patients have access to viral load testing, representing severe market shortcomings and a large opportunity for intervention.2 Today, measurement of blood plasma HIV-1 RNA concentration (known as HIV viral load) using nucleic acid-based molecular diagnostic assays has been established as the standard of care in assessing HIV-positive patient prognosis and response to antiretroviral therapy.3
The HIV Cascade to Ending AIDS by 2030
Initiated by WHO, The HIV Cascade to Ending AIDS by 2030, can only be achieved through multisectoral partnerships that provide access to diagnosis and care and bring HIV treatment to all who need it.
The Solution
Xpert HIV-1 Viral Load XC is a quantitative test that provides on-demand molecular testing.
Based on the GeneXpert® technology, Xpert HIV-1 Viral Load XC automates the test process including RNA extraction, purification, reverse transcription and real-time quantification in one fully integrated cartridge.
Dual Target Detection for Extended Coverage and Superior Performance
Easy
No requirements for separate PCR room settings
No daily maintenance or liquid waste management
Fast
No batching required*
Flexible
Compatible with any lab volume
Provides up to 403 viral load results per 8 hours^
Random access 24/7 availability
Run multiple different tests on the same platform at any time
* Trend report available for patients’ viral load measured multiple times on the same GeneXpert.